BridgeBio

BridgeBio is a biotechnology company headquartered in Palo Alto, California. With a small team of 3 employees, BridgeBio focuses on developing groundbreaking treatments for genetic diseases. The company has generated $70.9 million in revenue. BridgeBio's mission is to develop and deliver breakthrough medicines for patients with uncommon genetic diseases. They recognize that many genetic diseases affect small patient populations, often leading to a lack of treatment options. BridgeBio aims to address this gap by leveraging scientific advancements in genetic science to bring life-changing medicines to patients as quickly as possible. BridgeBio distinguishes itself through its entrepreneurial approach, aiming to bridge the gap between scientific possibilities and patient needs. The company emphasizes developing both innovative drugs and future leaders within the biotechnology field. BridgeBio can be reached through their website at bridgebio.com.